The Host Defense Laboratory uses basic, translational and clinical research to understand immune responses that combat pathogens and tumors and develop immunotherapeutics and vaccines.

Our objectives

Our lab aims to develop a nanoparticle-based vaccine platform to boost antigen-specific immunity against tumors and intracellular pathogens. We also explore sex steroid-mediated effects on epithelial cell proliferation and differentiation to enhance epithelial barrier protection
 

Our team

Cherpes 460x460

Thomas Cherpes, MD, DVM

Lab director

Notable achievements

Our publications

Current clinical trials, research studies and support

Contact us to learn more about our lab or make a referral

Email: Cherpes.1@osu.edu
Phone: 614-685-0903